“The Last Shift” Oil on clay covered wood board by C. Michael Gibson 2020. Welcome home to all of our courageous #CoronaHeroes who made the ultimate sacrifice 🙏💙 #cmgsees #COVID19

🏥 PRECISE-HBR score is a new, simple 7-item risk score to predict post-PCI #bleeding: 📌 in the whole spectrum of #PCI patients, including those on #OAC 💊 📌 with #superior discrimination over the PRECISE-DAPT and ARC-HBR scores 🩸 ahajournals.org/doi/10.1161/CI… Circulation Marco Valgimigli

instagram.com/p/DCH4IDIh5Cy/…

#GISE24 meeting the expert ⁦Francesco Pelliccia⁩ #TAVR #SAPT

🔴 Clot-in-transit & pulmonary embolism: an urgent call for awareness and action Heart_BMJ #cardioEd #Cardiology #CardioTwitter #echofirst

Pulmonary embolism and clot in transit- a proposed algorithm where the role of the Pulmonary Embolism Response Team (PERT) is highlighted for risk stratification and treatment Work led by Marco Zimarino and mario di marino and friends Link to paper ➡️heart.bmj.com/content/early/… Thank

The article led by Vincenzo De Sio Felice Gragnano from the team of Pr Paolo Calabro has been accepted. With several “usual suspects” Mattia Galli Francesco Pelliccia et al ☀️

📢 Antithrombotic therapy in patients with #AHREs: Current evidence and open questions just discussed in a new review article in International Journal of Cardiology 📚 sciencedirect.com/science/articl… Paolo Calabro' Vincenzo De Sio Arturo Cesaro SABOURETCardiologist Mattia Galli Francesco Pelliccia Erik Lerkevang Grove #Cardiology

linkedin.com/posts/giorgio-…

TAVR is more common in the US, but TAVI is the acronym of choice in Europe/Asia. Is one better or is it OK to have both? Thanks to all who lent their opinions Marty Leon Prof. Ciro Indolfi megan coylewright md mph Tsuyoshi Kaneko Eliano Navarese David J. Cohen, MD, MSc Francesco Pelliccia tctmd.com/news/whats-nam…

What’s in a Name: Is It Time to Choose Between TAVI and TAVR? tctmd.com/news/whats-nam…

Yael L. Maxwell Marty Leon Prof. Ciro Indolfi megan coylewright md mph Tsuyoshi Kaneko Eliano Navarese David J. Cohen, MD, MSc Francesco Pelliccia I always stick to the original ! I even still say NAFLD and NASH, so it is TAVI

Last week, I sat down with Marat Fudim, MD MHS and Rishi K Trivedi, MD PhD at #ACC25 to talk about interventional heart failure training and how the paradigm is shifting for TCTMD's #FellowsForum. tctmd.com/videos/formali…

🏆We are thrilled to honor Dr. Roxana Mehran (Dr Roxana Mehran) with this year's #TCTAP2025 Master of the Master's Award! Thank you Dr. Mehran for your extraordinary impact as a true global icon in interventional cardiology! 💙👏 🔗Find Out More: summit-tctap.com/2025/program_a…

Allen Jeremias Sanjit Jolly Francesco Pelliccia Karim Al-Azizi, MD Chadi Alraies, MD FACC FSCAI Ajar Kochar Saraschandra Vallabhajosyula, MD MSc @DangasKate67676 Current guidelines recommend SAPT after #TAVR in patients without an indication for anticoagulation. Read the abstract by Francesco Pelliccia to learn about the insights from the TRITAVI Registry ➡️ scai.confex.com/scai/2025/meet… #SCAI2025 #LateBreaking #Cardiology #Research

🎉 Congratulations and welcome to this year’s new FSCAIs! 👏 We’re proud to celebrate your achievement at #SCAI2025! Binita Shah

🎙️NEW #SCAI2025 #LBCT Interview 💫Dr Francesco Pelliccia discusses insights from the #TRITAVI registry. 📽️Watch here👉 ow.ly/fQ1950VPpJx #IC #PCI #CardioEd

🎙️NEW #SCAI2025 #LBCT Interview 💫Dr Karim Al-Azizi, MD discusses a study on prosthesis-patient mismatch in patients undergoing #TAVI. 📽️Watch here👉 ow.ly/VSEg50VPqqL #IC #PCI #CardioEd

New guidelines help interventional cardiologists manage chronic venous disease | ⁦SCAI⁩ All 4 areas of IC - coronary, structural, endo and congenital - continue to grow. Here we tackle chronic venous disease intervention. cardiovascularbusiness.com/topics/clinica…